Hooda N, Suh M, Bylsma LC, Kelsh M. A systematic literature review of the association between dose reduction of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors and survival in patients with HR-positive breast cancer (BC). Poster 1882eP, European Society for Medical Oncology (ESMO) Congress 2026, Madrid, Spain, October 23-27, 2026.

View Abstract

Kopanska K, Rovida C, Antignac E, Barton-Maclaren T, Congreave I, Escher SE, Herzler M,…, Patlewicz G, et al. From thresholds to odds: AI-enhanced applications of the threshold of toxicological concern (TTC) in modern risk assessment. Oral Session 3, Poster OR-12, American Society for Cellular and Computational Toxicology (ASCCT) 15^th Annual Meeting, Durham, NC, October 28, 2026.

View Abstract